Document Detail

Mobilisation kinetics of primitive haemopoietic cells following G-CSF with or without chemotherapy for advanced breast cancer.
MedLine Citation:
PMID:  9037364     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: The objective of this study was to determine the optimal conditions for blood progenitor cell harvest for transplantation, with main emphasis on the mobilisation kinetics of primitive, marrow repopulating cells. PATIENTS AND METHODS: Sixteen patients with advanced breast cancer were treated with 4 cycles of dose escalating FAC chemotherapy (5-fluorouracil, adriamycin, cyclophosphamide) each followed by 10 micrograms/kg/d G-CSF for 13 days. We assessed the number of colony-forming cells (CFC), and estimated the long-term culture initiating cells (LTC-IC) and CD34+ cells during the recovery phase of cycle 1 and 4 of chemotherapy, and during additional periods of G-CSF administration either preceding or following the full course of chemotherapy. RESULTS: The highest peak numbers of CFC per ml of blood (median 10489, range 860-39282) were mobilised after the first cycle of chemotherapy. The lowest peak numbers of CFC were obtained during the recovery phase from cycle 4 (median 4739, range 40-26789). In contrast, the numbers of CD34+ cells per ml of blood were significantly higher in cycle 4 (median 650, range 30-2600 x 10(2)) compared to those of cycle 1 (median 240, range 20-770 x 10(2)). The peak numbers of CFC mobilised by G-CSF before commencement and after the cessation of chemotherapy were equivalent, with a median of 5470 (range 1056-25669) and 5948 (range 2710-38975) per ml of blood, respectively. However, while mononuclear cells (MNC) collected at the days of maximal CFC mobilization following G-CSF administration before or after cycle 1 were similar to normal bone marrow MNCs in their ability to generate haemopoiesis when seeded onto performed irradiated stroma, those collected after cycle 4 or during G-CSF administration after the cessation of chemotherapy were markedly compromised in this respect. CONCLUSIONS: Our results indicate that repeated cycles of FAC chemotherapy followed by G-CSF result in a far lower number of LTC-IC than of CFC mobilised into the circulation. Furthermore although the combination of chemotherapy and G-CSF mobilised the highest numbers if CFC, G-CSF alone pre-chemotherapy was more effective at mobilising LTC-IC. These data indicate that neither the numbers of CFC mobilised nor the numbers of CD34+ cells are necessarily a reliable indicator for the putative marrow repopulating capability of the blood cells mobilised with chemotherapy plus G-CSF.
I Baumann; R Swindell; M E Van Hoeff; T M Dexter; E de Wynter; C Lange; T Luft; A Howell; N G Testa
Related Documents :
1967604 - Autologous transplantation with peripheral blood stem cells: a review of clinical results.
19851434 - Rituximab does not adversely affect the stem cell mobilization and engraftment after hi...
145164 - Normal chemotactic activity of granulocytes obtained by filtration leucapheresis.
10960524 - In vitro collection and posttransfusion engraftment characteristics of mncs obtained by...
8622884 - Expression of cell-cycle regulatory genes in htlv-i infected t-cell lines: possible inv...
8558914 - The adhesion molecule e-cadherin and a surface antigen recognized by the antibody 9c4 a...
Publication Detail:
Type:  Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Annals of oncology : official journal of the European Society for Medical Oncology / ESMO     Volume:  7     ISSN:  0923-7534     ISO Abbreviation:  Ann. Oncol.     Publication Date:  1996 Dec 
Date Detail:
Created Date:  1997-05-28     Completed Date:  1997-05-28     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9007735     Medline TA:  Ann Oncol     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  1051-7     Citation Subset:  IM    
Department of Experimental Haematology, Paterson Institute for Cancer Research, Manchester, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antigens, CD34 / analysis
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Breast Neoplasms / drug therapy*,  immunology,  pathology
Combined Modality Therapy
Cyclophosphamide / administration & dosage
Doxorubicin / administration & dosage
Filgrastim / administration & dosage*
Fluorouracil / administration & dosage
Hematopoietic Stem Cells / physiology
Middle Aged
Reg. No./Substance:
0/Antigens, CD34; 0/CAF protocol; 121181-53-1/Filgrastim; 23214-92-8/Doxorubicin; 50-18-0/Cyclophosphamide; 51-21-8/Fluorouracil

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Intensive therapy and autotransplant for patients with an incomplete response to front-line therapy ...
Next Document:  Pretransplant malignancy in candidates and posttransplant malignancy in recipients of cardiac transp...